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OBJECTIVES We evaluated whether delayed contrast-enhanced magnetic resonance imaging (DCE-MRI)
using an extracellular contrast agent could predict improvement of dysfunctional but viable
myocardium after acute reperfused myocardial infarction (MI).
BACKGROUND The transmural extent of hyperenhancement at DCE-MRI has been related to improvement
of function in reperfused MI. However, evidence is still limited, and earlier reports have
produced conflicting results regarding the significance of contrast patterns after infarction.
METHODS Thirty patients (mean age 59  11 years, 27 males) underwent cine MRI and DCE-MRI 7
 3 days after a first reperfused acute MI and follow-up cine MRI at 13  3 weeks.
Segmental wall thickening and segmental extent of hyperenhancement were scored in 1,689
segments.
RESULTS Of 500 dysfunctional segments, 273 (55%) improved at follow-up. There was no difference
in likelihood of improvement or complete functional recovery between segments with 0% and
1% to 25% hyperenhancement. The likelihood of improvement of segments without
hyperenhancement was 2.9, 14.3, and 20 times higher than that of segments with 26% to
50%, 51% to 75%, and75% hyperenhancement, respectively (p 0.001). The likelihood of
complete functional recovery of segments without hyperenhancement was 3.8, 11.1, and 50
times higher than that of segments with 26% to 50%, 51% to 75%, and 75% hyperen-
hancement, respectively (p  0.001).
CONCLUSIONS In patients with recent reperfused MI, functional improvement of stunned myocardium is
predicted by DCE-MRI. (J Am Coll Cardiol 2003;42:895–901) © 2003 by the American
College of Cardiology Foundation
The recognition of stunned myocardium early after acute
myocardial infarction (AMI) has important prognostic and
therapeutic implications (1). Using low-dose dobutamine
echocardiography and 18F-fluorodeoxyglucose–positron
emission tomography, a subgroup of patients with residual
myocardial viability has been identified that is at high risk
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for future clinical events (2,3). Contrast-enhanced magnetic
resonance imaging (MRI) using an extracellular contrast
agent such as gadolinium–diethylenetriamine pentaacetic
acid (Gd-DTPA) has been applied extensively for the
evaluation of myocardial injury after AMI (4–11). In a
recent series of studies using canine infarction models, it has
been shown that hyperenhancement on T1-weighted de-
layed contrast-enhanced magnetic resonance imaging
(DCE-MRI) (originally described as images acquired more
than 10 min after contrast injection) only occurred in
necrotic, irreversibly injured myocardium, irrespective of the
age of the infarct (12,13). The high signal intensity is
related to a regional increased concentration of the contrast
agent, most likely caused by ischemia-related changes in the
volume of distribution and contrast kinetics (14–16). The
regional extent of hyperenhancement has been shown to
predict functional improvement of stunned myocardium,
both in a canine model and recently also in patients with
reperfused myocardial infarction (MI) (10,11,17). However,
evidence is still limited, and earlier reports have produced
conflicting results on the significance of contrast patterns
after MI. Several investigators have demonstrated that the
hyperenhanced region overestimates the actual necrotic
region, and that it contains residual viable myocardium that
may recover function when adequately reperfused (8,18,19).
Comparison between these studies is hampered by consid-
erable methodological differences, including the MRI tech-
nique that was used, the contrast dose, and the clinical or
experimental setting. The current standard DCE-MRI
technique combines optimal image quality, high spatial
resolution, and contrast-to-noise and is a promising tool for
the transmural evaluation of myocardial viability (10,11,20).
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We therefore conducted a prospective study to evaluate the
role of this DCE-MRI technique in the prediction of
functional improvement in patients with first AMI.
METHODS
Patient population. Patients were eligible for the study if
admitted with first AMI according to standard electrocar-
diogram (ECG) and enzymatic criteria. Only patients with
direct (coronary catheterization, Thrombolysis In Myocar-
dial Infarction flow grade 3 in the infarct-related artery) or
indirect (rapid decrease of symptoms and more than 50%
resolution of ST elevation on ECG, either during or after
thrombolytic therapy or spontaneous) evidence of successful
reperfusion were included. Exclusion criteria were hemody-
namic instability, failure to give informed consent, or any
relative or absolute contraindication for MRI. The study is
part of a larger project evaluating the current role of
contrast-enhanced MRI in patients with suspected ischemic
heart disease, which was approved by the Committee on
Research Involving Human Subjects of the Vrije Univer-
siteit Medical Center. Thirty-nine patients were initially
enrolled. Nine patients were excluded from the final analy-
sis: one patient had significant valvular disease, four patients
were lost to follow-up, and four patients had insufficient
image quality of either baseline or follow-up MRI study.
The clinical characteristics of the remaining 30 patients are
listed in Table 1. Five patients (4 spontaneous symptom and
ECG resolution, 1 thrombolysis) were revascularized be-
tween the baseline and follow-up MRI study. In three of
these, percutaneous transluminal coronary angioplasty
(PTCA) of the infarct-related artery was performed before
discharge because of symptomatic ischemia during exercise
testing. Two patients were readmitted with unstable angina
pectoris with negative cardiac enzymes and underwent
PTCA (of the infarct-related artery) and coronary artery
bypass graft surgery, respectively.
MRI. All MRI procedures were performed with the pa-
tient in supine position in a 1.5-T clinical scanner (Sonata/
Vision, Siemens, Erlangen, Germany) using a four-element
phased array cardiac receiver coil. The ECG-gated images
were acquired during repeated breath-holds of varying
duration depending on heart rate (10 s). Cine images
using a segmented gradient-echo sequence (6-mm slice
thickness) were obtained in multiple short-axis views every
10 mm covering the whole left ventricle (LV). Ten to
15 min after injection of a gadolinium-based contrast agent
(Magnevist, Schering AG, Berlin, Germany; 0.2 mmol/kg),
DCE images were acquired in the same orientation as the
cine images using a segmented inversion-recovery gradient-
echo pulse sequence (repetition time/echo time  9.6/4.4
ms, flip angle 25°, matrix 208  256 and a typical voxel size
of 1.6 1.3 5.0 mm, inversion time [TI] 250 to 300 ms).
The baseline study was performed 7  3 days after admis-
sion, with follow-up at 13  3 weeks. The DCE images
were acquired only during the baseline study.
Data analysis. All data were analyzed on a separate work-
station (Sun Microsystems, Inc., Santa Clara, California)
using a dedicated software package (Mass, Medis, Leiden,
The Netherlands). Baseline cine images and contrast-
enhanced images were matched by using slice position, because
both data sets were acquired during the same imaging session.
Registration of follow-up to baseline cine images was achieved
by consensus of two observers using various anatomic land-
marks, including the septal insertion sites of the right ventricle,
the papillary muscles, and trabecularization patterns in the
right ventricle and LV. Images were then analyzed by consen-
sus of two observers who were blinded to patient data and the
results of the other examinations.
Segmental analysis. For analysis of segmental function
and contrast pattern, the two most basal and two most distal
slices were excluded, because short-axis images at these
levels preclude a reliable segmental evaluation owing to the
presence of the LV outflow tract and small diameter,
respectively. Each short axis was divided in 12 equi-angular
segments, starting at the posterior septal insertion of the
right ventricle. Segmental wall thickening (SWT) was
scored according to the following scale: 1—normal, 2—mild
hypokinesis, 3—severe hypokinesis, 4—akinesis, 5—dyski-
nesis. Functional improvement was defined as a decrease in
SWT score of 1. Complete recovery was defined as a
Abbreviations and Acronyms
AMI  acute myocardial infarction
CK  creatine kinase
DCE  delayed contrast-enhanced
DTPA  diethylenetriamine pentaacetic acid
ECG  electrocardiogram
EF  ejection fraction
MI  myocardial infarction
MRI  magnetic resonance imaging
PTCA  percutaneous transluminal coronary angioplasty
SEH  segmental extent of hyperenhancement
SEHth  SEH scored after thresholding the window
setting of contrast images
SWT  segmental wall thickening
TI  inversion time
Table 1. Patient Characteristics
Number of patients 30
Male 28
Age (yrs) 59  11
Infarct site ECG
Anterior 13
Inferior (lateral) 11
Posterior 6
Maximum total CK (U/l) 2,190  1,364
Maximum MB fraction 178  110
Ejection fraction baseline (%) 51  9
Thrombolysis 5
Primary PTCA 8
Days between admission and baseline MRI 7  3
Weeks between admission and follow-up MRI 13  3
CK  creatine kinase; ECG  electrocardiogram; MRI  magnetic resonance
imaging; PTCA  percutaneous coronary transluminal angioplasty.
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decrease to SWT score 1. Interobserver variability (A.M.B.,
H.P.K.) was tested in 10 patients (532 segments).
For analysis of the DCE images, the segmental extent of
hyperenhancement (SEH) was calculated by dividing the
hyperenhanced area by the total area of the predefined segment
expressed as percentage. Any subendocardial area of hypoen-
hancement within the hyperenhanced area was considered part
of the hyperenhanced area. The SEH was then scored as
follows: 1—0%; 2—1% to 25%; 3—26% to 50%; 4—51% to
75%; 5—76% to 100% hyperenhancement (10). To explore the
relationship between DCE-MRI and change in ejection frac-
tion (EF), we calculated a viability score in each patient as
follows: the total number of segments with baseline wall
thickening abnormality and SEH score 2, divided by all
segments with baseline wall thickening abnormality.
The assessment of contrast images and the size of the
hyperenhanced areas are sensitive to image window setting.
To eliminate the influence of subjective window setting, SEH
was scored again after thresholding the images at 6 SD above
signal intensity of the opposite, non-infarcted myocardium in
the same slice (SEHth). The choice of 6 SD as the cutoff value
was based on our own clinical experience and recent literature
(21). To test the interobserver variability (A.M.B., O.B.), SEH
was scored independently in five patients (299 segments), with
window setting adjusted to personal preference.
Global analysis. On all short-axis cine slices, the endocar-
dial and epicardial borders were outlined manually in end-
diastolic and end-systolic images, excluding trabeculae and
papillary muscles. The EF was calculated as follows: (end-
diastolic volume end-systolic volume)/end-diastolic volume.
Statistical analysis. The paired sample t test and the
independent samples t test were used to compare means
within the study group or between subgroups. We used
kappa values to assess interobserver variability and enhance-
ment score (SEH and SEHth) variability. Because wall
thickening scores within one patient are strongly related, we
used multilevel logistic regression to evaluate the relation-
ship between change in wall thickening and baseline hyper-
enhancement score (MLwiN, version 1.02.0002, Centre for
Multilevel Modelling, London, United Kingdom) (22,23).
Multilevel analysis can be considered an extension to the
commonly used repeated measures analysis of variance,
which has the disadvantage that only a continuous outcome
variable can be analyzed. Furthermore, repeated measures
analysis of variance requires a fully balanced data set and
only corrects for correlated observations at one level. In this
study, two dichotomous outcome variables were analyzed
(improvement and complete recovery), with correlated ob-
servations at two levels (i.e., slices within patients and
segments within slices). A correction was made for baseline
wall thickening scores, and the regression equation was used
to calculate odds ratios that expressed the likelihood of
improvement relative to functional outcome of segments
without hyperenhancement (SEH score 1). The relation-
ship between change in EF and various patient variables was
evaluated using logistic regression.
RESULTS
A total of 1,740 segments (4.8 slices/patient) were available
for analysis. During the analysis, 51 (3%) segments were
additionally excluded because assessment was considered
not reliable on any of the cine or contrast images by at least
one of the two observers (e.g., presence of LV outflow tract,
localized artifacts).
Cine MRI. Of 1,689 segments, 500 (30%) showed a
baseline wall thickening abnormality. In these, baseline
mean SWT score was 3.2  0.9. At follow-up, mean SWT
score had decreased to 2.5  1.3 (p  0.001 vs. baseline).
Fifty-five percent (273 of 500) of segments improved at
follow-up, 7% (36 segments) worsened, and 38% (191
segments) remained unchanged. Interobserver agreement
for the assessment of SWT was 85% (kappa  0.69).
DCE-MRI. Twenty-nine patients showed regional hyper-
enhancement, and in all patients the area corresponded to
the electrocardiographic infarct location. One patient with a
small inferior infarction (maximum creatine kinase [CK] 
426 U/l) had no regional hyperenhancement. The inter-
observer agreement for the assessment of SEH was 87%
(kappa  0.76).
Segments that improved had lower mean SEH score than
segments that did not improve (2.4 1.3 vs. 3.7 1.4; p
0.001). The functional change according to SEH is shown
in Figure 1A and Table 2. Of 151 segments with 25%
hyperenhancement that improved, 119 (79%) had complete
functional recovery, 25 (17%) residual mild hypokinesis, and
7 (5%) residual severe hypokinesis. Of the 31 segments with
75% hyperenhancement that improved, only 4 (13%) had
complete functional recovery, 9 (29%) residual mild hypo-
kinesis, and 17 (55%) initially akinetic segments and one
initially dyskinetic segment had residual severe hypokinesis.
Figure 2 illustrates the relationship between hyperenhance-
ment and change in wall thickening in a patient with recent
anterior MI (also see electronic data supplement at www.
cardiosource.com/jacc.html, September 3 JACC issue).
Multilevel analysis showed that the inverse relationship
between likelihood of improvement and SEH was highly
significant. Functional outcome in relation to contrast score
is shown in Table 3. The outcome was comparable in segments
with SEH scores 1 and 2. The likelihood of partial or complete
functional recovery of segments without hyperenhancement
(SEH score 1) was significantly higher than that of segments
with SEH scores 3, 4, and 5. Segments without hyperenhance-
ment were 20 and 50 times more likely to have partial or
complete recovery of function, respectively, than segments with
75% hyperenhancement (Table 3).
ANALYSIS USING STANDARDIZED WINDOW SETTING
(SEHTH). The overall agreement between the SEH score and
the SEHth score was 85% (kappa  0.70). Agreement was
lower when only the 500 segments with abnormal baseline
wall thickening were taken into account: 64% (SEH 
SEHth in 24% of segments, SEH  SEHth in 12% of
segments) (kappa 0.55). The functional change according
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to baseline SEHth is shown in Figure 1B and Table 2.
Multilevel analysis showed that the likelihood of partial or
complete functional recovery was similar for SEHth scores 1,
2, and 3 and was significantly lower for SEHth scores 4 and
5 (Table 3).
SUBENDOCARDIAL DARK ZONE. Sixty-five segments had a
subendocardial zone of low signal intensity within the
hyperenhanced region. Mean wall thickening score at base-
line in these segments was high (3.8  0.5) and remained
high at follow-up (3.8  0.6; p  NS). Only 10 of these
(15%) showed improvement: 6 initially akinetic segments
had residual severe hypokinesis, 3 akinetic segments had
residual mild hypokinesis, and only 1 segment had
complete recovery. Of the remaining 55 segments, 45
remained akinetic, 1 remained severely hypokinetic, and
9 worsened.
LVEF. Overall EF did not change at follow-up (0.51 
0.09 vs. 0.53  0.10, p  NS). Previous studies have
reported a significant relationship between the percentage
dysfunctional but viable myocardium and the change in EF
(10,21). We tested multiple patient-related and scan-related
variables for their ability to predict the change in EF at
follow-up: age; baseline EF; maximum CK; maximum CK,
MB fraction; the presence of a dark zone; and the viability
score. No significant predictors of change in EF could be
identified (Table 4). However, the study group was small,
and some variables (the viability score, presence of a dark
zone) might have reached statistical significance with a
larger study group size.
DISCUSSION
This study shows that DCE-MRI can be used to predict
improvement of dysfunctional but viable myocardium in
patients with recent reperfused MI. The likelihood of
functional improvement decreased with increasing SEH.
Multilevel logistic regression analysis, which takes into
account the fact that segments within one patient and one
slice are strongly correlated, showed that this inverse rela-
tionship was highly significant.
Hyperenhancement after recent MI. High-resolution ex-
perimental studies that used the current standard DCE-
MRI technique have demonstrated that hyperenhanced
areas correlate exclusively with irreversibly damaged, ne-
crotic myocardium at various time intervals after infarction
and irrespective of the status of the infarct-related artery
(12,13). Hillenbrand et al. (17) used a canine infarction
model to evaluate functional recovery after various occlusion
times and found that both likelihood of improvement and
change in absolute wall thickening were predicted by the
transmural extent of hyperenhancement. Using electron
probe X-ray microanalysis, Rehwald et al. (16) showed that
elevations in Gd-DTPA concentration only occur in regions
with histologically proven irreversible ischemic damage.
Our data are in line with these experimental and two recent
clinical studies that used the same MRI technique to
evaluate viability after recent MI. Choi et al. (10) studied 24
patients one week and 16  6 weeks after infarction and
found that the transmural extent of hyperenhancement
strongly predicted functional improvement. Gerber et al.
(11) evaluated 20 patients with contrast-enhanced MRI and
myocardial tagging and found that improvement in circum-
ferential shortening was inversely related to the regional
extent of hyperenhancement at delayed imaging. Compared
with Choi et al. (10), we found that more segments with
75% hyperenhancement improved at follow-up (25% [31
of 125] vs. 5% [3 of 64]), although the majority of these
segments had severe residual dysfunction and only four had
complete recovery. Gerber et al. (11) reported the mean
functional improvement but did not state the percentage of
segments with 75% hyperenhancement that improved.
Hillenbrand et al. (17) also found some improvement (12%)
Figure 1. Functional outcome of dysfunctional segments according to
baseline segmental extent of hyperenhancement (A  SEH; B  SEHth).
CR  complete recovery. Also see Table 2.
898 Beek et al. JACC Vol. 42, No. 5, 2003
Delayed Contrast-Enhanced MRI After MI September 3, 2003:895–901
in segments with extensive enhancement in their canine
experiment. Results of the highly detailed experimental
studies make it unlikely that Gd-DTPA accumulates in
reversibly damaged myocardium, although one cannot en-
tirely exclude the possibility that distribution of Gd-DTPA
in human and canine infarcts is different. However, several
other factors may have played a role.
An important issue and potential source of error was
recently evaluated by Oshinski et al. (24), who found that
MRI overestimated infarct size in a rat model of reperfused
infarction when images were acquired too early after con-
trast injection. However, these authors used a different pulse
sequence (single slice spin-echo sequence with an acquisi-
tion time of 2 to 3 min) with a fixed TI and a different
contrast dose (0.03 mmol/kg), which interferes with extra-
polation of their results to our study (25). In the literature,
the time between contrast injection and data acquisition
varies considerably, between 5 and 30 min (8,12,13,17,
18,20). In our study, DCE-MRI data acquisition was
started 10 to 15 min after contrast injection, and we did not
notice a decrease in hyperenhanced area over time. How-
ever, we did not systematically evaluate time dependency of
size of infarction, and future study is required.
Another possible cause of error is related to the use of
qualitative assessment of regional wall thickening. Tether-
ing of largely non-viable segments to surrounding viable
segments regaining contraction may falsely give the impres-
sion of improved function (17). In segments with 75%
hyperenhancement, the likelihood of improvement was
twice the likelihood of complete recovery, which suggests
that it may be more difficult to establish partial recovery
with severe residual dysfunction than complete recovery. In
addition, all studies that use the change in regional wall
thickening as the standard of viability require accurate
registration of baseline and follow-up images. Despite the
use of standard imaging procedures and anatomic land-
marks, misregistration may be caused by infarct sequels as
scar formation and remodeling.
Table 2. Number of Segments With Functional Improvement and CR at Follow-Up According
to Baseline SEH- and SEHth-score*
SEH
Total 108 92 105 70 125
Improved 83 68 70 21 31
CR 69 50 36 10 4
SEHth
Total 120 74 87 55 164
Improved 82 53 65 17 56
CR 70 39 41 7 12
SEH/SEHth-score 1 2 3 4 5
*Also see Figure 2.
CR  complete recovery; SEH  segmental extent of hyperenhancement; SEHth  SEH scored after thresholding the
images at 6 SD above signal intensity of the opposite, non-infarcted myocardium in the same slice.
Figure 2. Three-chamber view and short axis view in a patient 5 days and 12 weeks after primary percutaneous transluminal coronary angioplasty plus
stenting of the left anterior descending coronary artery for anterior myocardial infarction. Baseline cine (left) shows severe wall thickening abnormality
(black arrows) in the anteroseptal, anterior, and apical region. Follow-up cine (right) shows no improvement in the area with transmural
hyperenhancement, whereas some improvement can be seen in the areas with non-transmural hyperenhancement (white arrows). To view cines in motion,
please see the accompanying videos corresponding to Figure 2 (Videos 1, 2, 3, and 4) at www.cardiosource.com/jacc.html (see September 3 JACC issue).
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Definition of hyperenhancement— current limitations of
DCE-MRI. During data acquisition, the area of hyperen-
hancement is defined by suppressing the signal of remote
myocardium without elevated Gd-DTPA concentrations.
Therefore, DCE-MRI may be less reliable when there is
coexisting myocardial disease with diffuse or regional fibro-
sis. In addition, careful optimization and continuous adjust-
ment of the TI is required, because ongoing wash-out of
contrast in remote, non-infarcted myocardium causes con-
tinuous change of myocardial relaxation parameters (20).
Currently, the correct choice of TI largely depends on the
experience of the operator, making it a potential source of
error. Newer reconstruction methods that are more
operator-independent are being developed (26).
During image analysis, the definition of hyperenhance-
ment is not standardized. Signal intensities and area of
enhancement are influenced by window setting, which may
inappropriately define segmental viability status. Animal
studies have used objective thresholds related to the nulled
signal of remote, non-enhanced myocardium, defining “hy-
perenhanced” as more than 2 or 3 SD above the mean signal
intensity of remote (12,13,17,27). Studies in patients have
generally not reported the use of objective definitions of
hypoenhancement and hyperenhancement (8,10,18,28). In
our experience, thresholding the images at 2 or 3 SD above
remote grossly overestimates the visually determined areas.
Signal intensity of remote myocardium is actively sup-
pressed and is therefore so low that areas that have only
marginally higher signal intensity are falsely considered part
of the infarcted area. In a group of patients with chronic
ischemic heart disease, Kim et al. (21) reported that signal
intensity in regions of interest within the hyperenhanced
infarcted area was always more than 6 SD above non-
enhanced remote regions, although this was not used in the
actual analysis. In the subset of segments with baseline
abnormal wall thickening, we found that SEHth scores
correlated only moderately with the SEH scores (agreement
64%, overestimating in 24%, kappa 0.55). Multilevel anal-
ysis showed that the discriminative power of SEHth was
smaller than that of SEH, because only SEHth scores 4 and
5 had significantly lower likelihood of improvement than
SEHth score 1. In addition, we found that on some
occasions the presence of a dark zone could only be
recognized on the non-thresholded images. The interob-
server agreement between two observers who independently
drew myocardial contours and adjusted window setting for
non-thresholded SEH in our study was good (87%, kappa
 0.76).
Hypoenhancement at delayed imaging. Low signal inten-
sity (hypoenhancement) during the first 2 min after contrast
injection is attributed to microvascular obstruction (7,15). It
is associated with greater myocardial damage and identifies
patients with worse prognosis (7,28,29). Signal intensity in
these dark zones rises slowly in the first 5 to 10 min after
contrast injection (7,15). The extent of hypoenhancement
may vary with the time after injection, because it is unlikely
that the degree of microvascular damage is identical
throughout the entire infarct. Some areas may have mild
damage and allow slow contrast wash-in by diffusion from
surrounding regions with intact microcirculation (Fig. 3)
(30). Others may have extensive microvascular damage,
resulting in persistent hypoenhancement even at late
imaging. We found that segments with dark zones within
the hyperenhanced areas at delayed imaging had poor
function with very low likelihood of improvement at
follow-up.
In conclusion, this study shows that DCE-MRI can be
used to predict improvement of dysfunctional but viable
segments in patients with recent reperfused MI. Future
study should focus on further standardization of scan
procedures and image analysis.
Table 3. Multilevel Logistic Regression Analysis*
Improvement Complete Recovery
OR p OR p
SEH score 2 0.63 (0.26–1.55) 0.32 0.81 (0.36–1.82) 0.61
3 0.35 (0.14–0.88) 0.03 0.26 (0.11–0.59) 0.00
4 0.07 (0.03–0.20) 0.00 0.09 (0.03–0.26) 0.00
5 0.05 (0.02–0.13) 0.00 0.02 (0.01–0.11) 0.00
SEHth score 2 0.66 (0.26–1.55) 0.32 0.70 (0.31–1.61) 0.41
3 0.79 (0.34–1.86) 0.59 0.52 (0.22–1.23) 0.14
4 0.12 (0.04–0.34) 0.00 0.10 (0.03–0.37) 0.00
5 0.09 (0.04–0.23) 0.00 0.03 (0.01–0.11) 0.00
*Odds ratios (95% confidence interval) represent likelihood of improvement or recovery relative to outcome of segments with
SEH and SEHth score 1.
Odds ratio (OR)  EXP (regression coefficient). Other abbreviations as in Table 2.
Table 4. Logistic Regression Analysis for the Prediction of the
Change in Ejection Fraction
Odds
Ratio 95% CI p
Age 1.00 0.93–1.08 0.93
CK 0.86 0.44–1.68 0.65
MB fraction 1.15 0.44–3.00 0.77
Presence of dark zone 2.40 0.48–12.13 0.29
Viability score (SEH  2) 1.40 0.95–2.07 0.10
CI  confidence interval; CK  creatine kinase; SEH  segmental extent of
hyperenhancement.
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Figure 3. Temporal changes in signal intensity after 0.2 mmol/kg gadolinium-DTPA administered intravenously in the same patient as Figure 2. Magnified
view of three-chamber view at 2 min (A), 15 min (B), and 30 min (C).
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